Impala Nordic has interviewed Jack Egelund Madsen, CEO of QNTM Labs ApS (“QNTM” or “the Company”), in the FinVoices podcast. 

QNTM is a private equity backed, Denmark-based analytical laboratory providing research, development and regulatory compliance services for the Danish and broader European pharmaceutical market.

Jack tells us about his background and the Company's ambitious growth plans. Jack also elaborates on the market that QNTM targets, the types of customers the Company serves and how QNTM differentiates itself from competitors. Jack also discusses the intention to raise additional capital to support strong growth.

Lastly, he shares the company’s biggest goal for 2025, which is to increase revenue fivefold. 

Click here to listen to the full interview